These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38521418)

  • 1. Antibiotic management programme in a tertiary intensive care unit: effects of a carbapenem-restricted period on clinical and laboratory parameters and costs of infections.
    Asiltürk D; Güner R; Kaya Kalem A; Özkoçak Turan I; Hasanoğlu I; Eser F; Malhan S; Kayaaslan B
    J Hosp Infect; 2024 Jun; 148():87-94. PubMed ID: 38521418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.
    Ogutlu A; Guclu E; Karabay O; Utku AC; Tuna N; Yahyaoglu M
    Ann Clin Microbiol Antimicrob; 2014 Jan; 13():7. PubMed ID: 24405720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a "handshake" stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome.
    Moghnieh R; Awad L; Abdallah D; Jadayel M; Sinno L; Tamim H; Jisr T; El-Hassan S; Lakkis R; Dabbagh R; Bizri AR
    J Chemother; 2020 Nov; 32(7):368-384. PubMed ID: 32364030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 5. Introducing an antibiotic stewardship program in a pediatric center in China.
    Zhang ZG; Chen F; Chen JZ
    World J Pediatr; 2018 Jun; 14(3):274-279. PubMed ID: 29508365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
    J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experience of an antimicrobial stewardship program and antibiotic consumption and resistance trends during the COVID-19 pandemic at a tertiary care center in Beirut.
    Haddad N; Zeenny RM; El Halabi C; Abdallah T; El Helou R; Zahreddine NK; Kanj SS; Rizk NA
    J Infect Public Health; 2024 Feb; 17(2):254-262. PubMed ID: 38128409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
    Munoz-Price LS; Zembower T; Penugonda S; Schreckenberger P; Lavin MA; Welbel S; Vais D; Baig M; Mohapatra S; Quinn JP; Weinstein RA
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1057-62. PubMed ID: 20715975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria.
    Spernovasilis N; Kritsotakis EI; Mathioudaki A; Vouidaski A; Spanias C; Petrodaskalaki M; Ioannou P; Chamilos G; Kofteridis DP
    J Antimicrob Chemother; 2023 Apr; 78(4):1000-1008. PubMed ID: 36790896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and resistance patterns of invasive
    Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
    J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a Carbapenem Antimicrobial Stewardship Program on Patient Outcomes.
    Seah VXF; Ong RYL; Lim ASY; Chong CY; Tan NWH; Thoon KC
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28717037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
    Cheon S; Kim MJ; Yun SJ; Moon JY; Kim YS
    Korean J Intern Med; 2016 Mar; 31(2):367-74. PubMed ID: 26874513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.
    Lew KY; Ng TM; Tan M; Tan SH; Lew EL; Ling LM; Ang B; Lye D; Teng CB
    J Antimicrob Chemother; 2015 Apr; 70(4):1219-25. PubMed ID: 25473028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis.
    Onorato L; Macera M; Calò F; Monari C; Russo F; Iovene MR; Signoriello G; Annibale R; Pace MC; Aurilio C; Gaeta GB; Coppola N
    Clin Microbiol Infect; 2020 Jun; 26(6):782.e1-782.e6. PubMed ID: 31678230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
    Lai CC; Shi ZY; Chen YH; Wang FD
    J Microbiol Immunol Infect; 2016 Feb; 49(1):74-82. PubMed ID: 26586483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.